首页> 外文期刊>中华医学杂志(英文版) >Effect of continuous positive airway pressure treatment on vascular endothelial function in patients with obstructive sleep apnea hypopnea syndrome and coronary artery disease
【24h】

Effect of continuous positive airway pressure treatment on vascular endothelial function in patients with obstructive sleep apnea hypopnea syndrome and coronary artery disease

机译:持续气道正压通气对阻塞性睡眠呼吸暂停低通气综合征和冠心病患者血管内皮功能的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Background Continuous positive airway pressure (CPAP) treatment has been proven to be effective in improving the symptoms of coexisting coronary heart disease (CHD) in patients with obstructive sleep apnea hypopnea syndrome (OSAHS). However, it is still unclear whether such improvements are linked to changes in vascular endothelial function. This research was carried out to investigate the effects of CPAP treatment on vascular endothelial function in patients with OSAHS and CHD.Methods Thirty-six patients with moderate or severe OSAHS and CHD undergoing three months of CPAP treatment were recruited for this study. The changes in their morning plasma nitric oxide (NO) and endothelin (ET) levels, NO/ET ratio, total ischemic burden (TIB) of the myocardium, apnea hypopnea index (AHI), and minimal and mean pulse oxygen saturation (SpO2) were compared and analyzed before and during CPAP treatment. Results Compared with the plasma levels of ET [(51.39±11.69) ng/L] and NO [(36.67±11.86) μmol/L], NO/ET (0.71±0.14), AHI (32.4±7.9), minimal SpO2 [(68.9±11.4)%], and myocardial TIB [(66.29±16.37) mm*min] before treatment, there were significant decreases in ET [(33.41±10.03) ng/L] (P<0.05), increases in NO [(59.89±10.26) μmol/L] and NO/ET (1.79±0.38) (P<0.01), decreases in AHI (1.9±0.5), and increases in minimal SpO2 [(90.6±1.8) %] (all P<0.01) and myocardial TIB [(36.42±10.87) mm*min] (P<0.05) after three months of CPAP treatment.Conclusion CPAP treatment may play an important role in the improvement and protection of vascular endothelial dysfunction and myocardial ischemia in OSAHS patients with CHD.
机译:背景技术经证明,持续气道正压(CPAP)治疗可有效改善阻塞性睡眠呼吸暂停低通气综合征(OSAHS)患者并存的冠心病(CHD)症状。但是,尚不清楚这种改善是否与血管内皮功能的改变有关。这项研究旨在探讨CPAP治疗对OSAHS和CHD患者血管内皮功能的影响。方法招募了36名接受CPAP治疗三个月的中度或重度OSAHS和CHD患者。早晨血浆一氧化氮(NO)和内皮素(ET)的水平,NO / ET比,心肌总缺血负荷(TIB),呼吸暂停低通气指数(AHI)以及最低和平均脉搏血氧饱和度(SpO2)的变化在CPAP治疗之前和期间进行了比较和分析。结果与血浆中ET [(51.39±11.69)ng / L]和NO [(36.67±11.86)μmol/ L],NO / ET(0.71±0.14),AHI(32.4±7.9),最低SpO2的血浆水平相比[ (68.9±11.4)%]和治疗前的心肌TIB [(66.29±16.37)mm * min],ET显着降低[(33.41±10.03)ng / L](P <0.05),NO升高[ (59.89±10.26)μmol/ L]和NO / ET(1.79±0.38)(P <0.01),AHI降低(1.9±0.5),最小SpO2升高[(90.6±1.8)%](所有P <接受CPAP治疗三个月后的0.01)和心肌TIB [(36.42±10.87)mm * min](P <0.05)。结论CPAP治疗可能在OSAHS患者的血管内皮功能障碍和心肌缺血的改善和保护中起重要作用与冠心病。

著录项

  • 来源
    《中华医学杂志(英文版)》 |2004年第6期|844-847|共4页
  • 作者单位

    Department of Respiratory Medicine, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China;

    Department of Respiratory Medicine, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China;

    Department of Respiratory Medicine, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China;

    Department of Respiratory Medicine, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China;

    Department of Respiratory Medicine, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 临床医学;
  • 关键词

    continuous positive airway pressure; endothelium, vascular; coronary arteriosclerosis; obstructive sleep apnea hypopnea syndrome;

    机译:持续气道正压;内皮;血管;冠状动脉硬化;阻塞性睡眠呼吸暂停低通气综合征;
  • 入库时间 2022-08-19 04:00:58
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号